Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: A meta-analysis

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sorlie, 2004, Molecular portraits of breast cancer: tumour subtypes as distinct disease entities, Eur J Cancer, 40, 2667, 10.1016/j.ejca.2004.08.021 Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 Brenton, 2005, Molecular classification and molecular forecasting of breast cancer: ready for clinical application?, J Clin Oncol, 23, 7350, 10.1200/JCO.2005.03.3845 Rouzier, 2005, Breast cancer molecular subtypes respond differently to preoperative chemotherapy, Clin Cancer Res, 11, 5678, 10.1158/1078-0432.CCR-04-2421 Sotiriou, 2003, Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci U S A, 100, 10393, 10.1073/pnas.1732912100 Herschkowitz, 2007, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, Genome Biol, 8, R76, 10.1186/gb-2007-8-5-r76 Carey, 2006, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492 Potti, 2006, Genomic signatures to guide the use of chemotherapeutics, Nat Med, 12, 1294, 10.1038/nm1491 O'Brien, 2010, Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina breast cancer study, Clin Cancer Res, 16, 6100, 10.1158/1078-0432.CCR-10-1533 Spitale, 2009, Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland, Ann Oncol, 20, 628, 10.1093/annonc/mdn675 Rakha, 2008, Basal-like breast cancer: a critical review, J Clin Oncol, 26, 2568, 10.1200/JCO.2007.13.1748 Weigelt, 2010, The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade, J Pathol, 220, 263, 10.1002/path.2648 Sotiriou, 2009, Gene-expression signatures in breast cancer, N Engl J Med, 360, 790, 10.1056/NEJMra0801289 Kreike, 2007, Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas, Breast Cancer Res, 9, R65, 10.1186/bcr1771 Reis-Filho, 2008, Triple negative tumours: a critical review, Histopathology, 52, 108, 10.1111/j.1365-2559.2007.02889.x Bryan, 2006, Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer, Mod Pathol, 19, 617, 10.1038/modpathol.3800570 Foulkes, 2010, Triple-negative breast cancer, N Engl J Med, 363, 1938, 10.1056/NEJMra1001389 Clarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016/S0140-6736(05)67887-7 Aebi, 2010, Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, v9, 10.1093/annonc/mdq159 Cardoso, 2010, Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, Ann Oncol, 21, v15, 10.1093/annonc/mdq160 Fisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056/NEJMoa022152 Veronesi, 2002, Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056/NEJMoa020989 Yang, 2008, Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials, Ann Oncol, 19, 1039, 10.1093/annonc/mdm573 Eiermann, 2012, Locoregional treatments for triple-negative breast cancer, Ann Oncol, 23, vi30, 10.1093/annonc/mds192 Parker, 2010, Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?, Surgery, 148, 386, 10.1016/j.surg.2010.05.018 Ho, 2012, Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy, Cancer, 118, 4944, 10.1002/cncr.27480 Voduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200/JCO.2009.24.9284 Adkins, 2011, Triple-negative breast cancer is not a contraindication for breast conservation, Ann Surg Oncol, 18, 3164, 10.1245/s10434-011-1920-z Ihemelandu, 2008, Treatment and survival outcome for molecular breast cancer subtypes in black women, Ann Surg, 247, 463, 10.1097/SLA.0b013e31815d744a Nguyen, 2008, Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy, J Clin Oncol, 26, 2373, 10.1200/JCO.2007.14.4287 Millar, 2009, Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel, J Clin Oncol, 27, 4701, 10.1200/JCO.2008.21.7075 Freedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002/cncr.24094 Haffty, 2006, Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer, J Clin Oncol, 24, 5652, 10.1200/JCO.2006.06.5664 Riley, 2003, Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future, Br J Cancer, 88, 1191, 10.1038/sj.bjc.6600886 Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 Boyle, 2012, Diabetes and breast cancer risk: a meta-analysis, Br J Cancer, 107, 1608, 10.1038/bjc.2012.414 Abdulkarim, 2011, Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy, J Clin Oncol, 29, 2852, 10.1200/JCO.2010.33.4714 Dragun, 2011, Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study, Am J Clin Oncol, 34, 231, 10.1097/COC.0b013e3181dea993 Gabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007/s10549-010-1135-1 Han, 2012, Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence, Clin Oncol (R Coll Radiol), 24, 183, 10.1016/j.clon.2011.09.008 Pashtan, 2012, External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study, Int J Radiat Oncol Biol Phys, 84, e271, 10.1016/j.ijrobp.2012.04.019 Hattangadi-Gluth, 2012, Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy, Int J Radiat Oncol Biol Phys, 82, 1185, 10.1016/j.ijrobp.2011.02.061 Arvold, 2011, Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy, J Clin Oncol, 29, 3885, 10.1200/JCO.2011.36.1105 Noh, 2011, Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype, J Breast Cancer, 14, 46, 10.4048/jbc.2011.14.1.46 Barbieri, 2011, Prognostic impact of triple negative phenotype in conservatively treated breast cancer, Breast J, 17, 377, 10.1111/j.1524-4741.2011.01100.x Zaky, 2011, The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy, Ann Surg Oncol, 18, 2858, 10.1245/s10434-011-1669-4 Wong, 2011, Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy, Ann Acad Med Singapore, 40, 7, 10.47102/annals-acadmedsg.V40N2p90 Siponen, 2011, Ipsilateral breast recurrence after breast conserving surgery in patients with small (</= 2 cm) breast cancer treated with modern adjuvant therapies, Eur J Surg Oncol, 37, 25, 10.1016/j.ejso.2010.11.003 Solin, 2009, Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma, Clin Breast Cancer, 9, 96, 10.3816/CBC.2009.n.018 Stang, 2010, Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z Arriagada, 1996, Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group, J Clin Oncol, 14, 1558, 10.1200/JCO.1996.14.5.1558 Blichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19 Fisher, 1989, Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer, N Engl J Med, 320, 822, 10.1056/NEJM198903303201302 Poggi, 2003, Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial, Cancer, 98, 697, 10.1002/cncr.11580 van Dongen, 1992, Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer, Eur J Cancer, 28A, 801, 10.1016/0959-8049(92)90118-L van Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093/jnci/92.14.1143 Veronesi, 1986, Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results, Eur J Cancer Clin Oncol, 22, 1085, 10.1016/0277-5379(86)90011-8 Kyndi, 2008, Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group, J Clin Oncol, 26, 1419, 10.1200/JCO.2007.14.5565 Yagata, 2011, Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy, Breast Cancer, 18, 165, 10.1007/s12282-011-0254-9 Veronesi, 2001, Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial, Ann Oncol, 12, 997, 10.1023/A:1011136326943 Carlson, 2009, Breast cancer. Clinical practice guidelines in oncology, J Natl Compr Canc Netw, 7, 122, 10.6004/jnccn.2009.0012 Valentin, 2012, Molecular insights on basal-like breast cancer, Breast Cancer Res Treat, 134, 21, 10.1007/s10549-011-1934-z Ueno, 2011, Targeting EGFR in triple negative breast cancer, J Cancer, 2, 324, 10.7150/jca.2.324